The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immune Cell Therapy Drugs Market Research Report 2025
Synopsis
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient's immune response against diseases like cancer.
The global Immune Cell Therapy Drugs market was valued at US$ 2456 million in 2023 and is anticipated to reach US$ 17140 million by 2030, witnessing a CAGR of 32.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immune Cell Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Cell Therapy Drugs.
Report Scope
The Immune Cell Therapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Cell Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Cell Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
Segment by Type
Monoclonal Antibodies
Immunomodulator
Other
Segment by Application
Stomach Cancer
lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Cell Therapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient's immune response against diseases like cancer.
The global Immune Cell Therapy Drugs market was valued at US$ 2456 million in 2023 and is anticipated to reach US$ 17140 million by 2030, witnessing a CAGR of 32.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immune Cell Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Cell Therapy Drugs.
Report Scope
The Immune Cell Therapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Cell Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Cell Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
Segment by Type
Monoclonal Antibodies
Immunomodulator
Other
Segment by Application
Stomach Cancer
lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Cell Therapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Immunomodulator
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Stomach Cancer
1.3.3 lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Drugs Market Perspective (2019-2030)
2.2 Immune Cell Therapy Drugs Growth Trends by Region
2.2.1 Global Immune Cell Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immune Cell Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Immune Cell Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Immune Cell Therapy Drugs Market Dynamics
2.3.1 Immune Cell Therapy Drugs Industry Trends
2.3.2 Immune Cell Therapy Drugs Market Drivers
2.3.3 Immune Cell Therapy Drugs Market Challenges
2.3.4 Immune Cell Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Cell Therapy Drugs Players by Revenue
3.1.1 Global Top Immune Cell Therapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Immune Cell Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Cell Therapy Drugs Revenue
3.4 Global Immune Cell Therapy Drugs Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Drugs Revenue in 2023
3.5 Immune Cell Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Immune Cell Therapy Drugs Product Solution and Service
3.7 Date of Enter into Immune Cell Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Drugs Breakdown Data by Type
4.1 Global Immune Cell Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Immune Cell Therapy Drugs Breakdown Data by Application
5.1 Global Immune Cell Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immune Cell Therapy Drugs Market Size (2019-2030)
6.2 North America Immune Cell Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immune Cell Therapy Drugs Market Size by Country (2019-2024)
6.4 North America Immune Cell Therapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Cell Therapy Drugs Market Size (2019-2030)
7.2 Europe Immune Cell Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immune Cell Therapy Drugs Market Size by Country (2019-2024)
7.4 Europe Immune Cell Therapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Immune Cell Therapy Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Cell Therapy Drugs Market Size (2019-2030)
9.2 Latin America Immune Cell Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immune Cell Therapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Immune Cell Therapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Immune Cell Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Detail
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Immune Cell Therapy Drugs Introduction
11.1.4 Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.1.5 Aquila BioMedical Recent Development
11.2 BPS Bioscience
11.2.1 BPS Bioscience Company Detail
11.2.2 BPS Bioscience Business Overview
11.2.3 BPS Bioscience Immune Cell Therapy Drugs Introduction
11.2.4 BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.2.5 BPS Bioscience Recent Development
11.3 Celentyx
11.3.1 Celentyx Company Detail
11.3.2 Celentyx Business Overview
11.3.3 Celentyx Immune Cell Therapy Drugs Introduction
11.3.4 Celentyx Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.3.5 Celentyx Recent Development
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Detail
11.4.2 Crown Bioscience Business Overview
11.4.3 Crown Bioscience Immune Cell Therapy Drugs Introduction
11.4.4 Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.4.5 Crown Bioscience Recent Development
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Detail
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Introduction
11.5.4 DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.5.5 DiscoverX Corporation Recent Development
11.6 Explicyte
11.6.1 Explicyte Company Detail
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Immune Cell Therapy Drugs Introduction
11.6.4 Explicyte Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.6.5 Explicyte Recent Development
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Detail
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Introduction
11.7.4 Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.7.5 Genscript Biotech Corporation Recent Development
11.8 HD Biosciences
11.8.1 HD Biosciences Company Detail
11.8.2 HD Biosciences Business Overview
11.8.3 HD Biosciences Immune Cell Therapy Drugs Introduction
11.8.4 HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.8.5 HD Biosciences Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Introduction
11.9.4 Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 ImmunXperts
11.10.1 ImmunXperts Company Detail
11.10.2 ImmunXperts Business Overview
11.10.3 ImmunXperts Immune Cell Therapy Drugs Introduction
11.10.4 ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.10.5 ImmunXperts Recent Development
11.11 Molecular Imaging
11.11.1 Molecular Imaging Company Detail
11.11.2 Molecular Imaging Business Overview
11.11.3 Molecular Imaging Immune Cell Therapy Drugs Introduction
11.11.4 Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.11.5 Molecular Imaging Recent Development
11.12 Promega Corporation,Personalis
11.12.1 Promega Corporation,Personalis Company Detail
11.12.2 Promega Corporation,Personalis Business Overview
11.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Introduction
11.12.4 Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.12.5 Promega Corporation,Personalis Recent Development
11.13 STC Biologics
11.13.1 STC Biologics Company Detail
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Immune Cell Therapy Drugs Introduction
11.13.4 STC Biologics Revenue in Immune Cell Therapy Drugs Business (2019-2024)
11.13.5 STC Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Immune Cell Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immunomodulator
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Immune Cell Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Immune Cell Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Immune Cell Therapy Drugs Market Share by Region (2019-2024)
Table 9. Global Immune Cell Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Immune Cell Therapy Drugs Market Share by Region (2025-2030)
Table 11. Immune Cell Therapy Drugs Market Trends
Table 12. Immune Cell Therapy Drugs Market Drivers
Table 13. Immune Cell Therapy Drugs Market Challenges
Table 14. Immune Cell Therapy Drugs Market Restraints
Table 15. Global Immune Cell Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Immune Cell Therapy Drugs Market Share by Players (2019-2024)
Table 17. Global Top Immune Cell Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2023)
Table 18. Ranking of Global Top Immune Cell Therapy Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Immune Cell Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immune Cell Therapy Drugs Product Solution and Service
Table 22. Date of Enter into Immune Cell Therapy Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Cell Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Immune Cell Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Immune Cell Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Immune Cell Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Immune Cell Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Immune Cell Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Immune Cell Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Immune Cell Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Immune Cell Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Immune Cell Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Immune Cell Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Aquila BioMedical Company Detail
Table 48. Aquila BioMedical Business Overview
Table 49. Aquila BioMedical Immune Cell Therapy Drugs Product
Table 50. Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 51. Aquila BioMedical Recent Development
Table 52. BPS Bioscience Company Detail
Table 53. BPS Bioscience Business Overview
Table 54. BPS Bioscience Immune Cell Therapy Drugs Product
Table 55. BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 56. BPS Bioscience Recent Development
Table 57. Celentyx Company Detail
Table 58. Celentyx Business Overview
Table 59. Celentyx Immune Cell Therapy Drugs Product
Table 60. Celentyx Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 61. Celentyx Recent Development
Table 62. Crown Bioscience Company Detail
Table 63. Crown Bioscience Business Overview
Table 64. Crown Bioscience Immune Cell Therapy Drugs Product
Table 65. Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 66. Crown Bioscience Recent Development
Table 67. DiscoverX Corporation Company Detail
Table 68. DiscoverX Corporation Business Overview
Table 69. DiscoverX Corporation Immune Cell Therapy Drugs Product
Table 70. DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 71. DiscoverX Corporation Recent Development
Table 72. Explicyte Company Detail
Table 73. Explicyte Business Overview
Table 74. Explicyte Immune Cell Therapy Drugs Product
Table 75. Explicyte Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 76. Explicyte Recent Development
Table 77. Genscript Biotech Corporation Company Detail
Table 78. Genscript Biotech Corporation Business Overview
Table 79. Genscript Biotech Corporation Immune Cell Therapy Drugs Product
Table 80. Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 81. Genscript Biotech Corporation Recent Development
Table 82. HD Biosciences Company Detail
Table 83. HD Biosciences Business Overview
Table 84. HD Biosciences Immune Cell Therapy Drugs Product
Table 85. HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 86. HD Biosciences Recent Development
Table 87. Horizon Discovery Group Company Detail
Table 88. Horizon Discovery Group Business Overview
Table 89. Horizon Discovery Group Immune Cell Therapy Drugs Product
Table 90. Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 91. Horizon Discovery Group Recent Development
Table 92. ImmunXperts Company Detail
Table 93. ImmunXperts Business Overview
Table 94. ImmunXperts Immune Cell Therapy Drugs Product
Table 95. ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 96. ImmunXperts Recent Development
Table 97. Molecular Imaging Company Detail
Table 98. Molecular Imaging Business Overview
Table 99. Molecular Imaging Immune Cell Therapy Drugs Product
Table 100. Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 101. Molecular Imaging Recent Development
Table 102. Promega Corporation,Personalis Company Detail
Table 103. Promega Corporation,Personalis Business Overview
Table 104. Promega Corporation,Personalis Immune Cell Therapy Drugs Product
Table 105. Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 106. Promega Corporation,Personalis Recent Development
Table 107. STC Biologics Company Detail
Table 108. STC Biologics Business Overview
Table 109. STC Biologics Immune Cell Therapy Drugs Product
Table 110. STC Biologics Revenue in Immune Cell Therapy Drugs Business (2019-2024) & (US$ Million)
Table 111. STC Biologics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immune Cell Therapy Drugs Market Share by Type: 2023 VS 2030
Figure 3. Monoclonal Antibodies Features
Figure 4. Immunomodulator Features
Figure 5. Other Features
Figure 6. Global Immune Cell Therapy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Immune Cell Therapy Drugs Market Share by Application: 2023 VS 2030
Figure 8. Stomach Cancer Case Studies
Figure 9. lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Immune Cell Therapy Drugs Report Years Considered
Figure 15. Global Immune Cell Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Immune Cell Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Immune Cell Therapy Drugs Market Share by Region: 2023 VS 2030
Figure 18. Global Immune Cell Therapy Drugs Market Share by Players in 2023
Figure 19. Global Top Immune Cell Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2023
Figure 21. North America Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Immune Cell Therapy Drugs Market Share by Country (2019-2030)
Figure 23. United States Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Immune Cell Therapy Drugs Market Share by Country (2019-2030)
Figure 27. Germany Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Immune Cell Therapy Drugs Market Share by Region (2019-2030)
Figure 35. China Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Immune Cell Therapy Drugs Market Share by Country (2019-2030)
Figure 43. Mexico Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Immune Cell Therapy Drugs Market Share by Country (2019-2030)
Figure 47. Turkey Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Immune Cell Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Aquila BioMedical Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 50. BPS Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 51. Celentyx Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 52. Crown Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 53. DiscoverX Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 54. Explicyte Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 55. Genscript Biotech Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 56. HD Biosciences Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 57. Horizon Discovery Group Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 58. ImmunXperts Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 59. Molecular Imaging Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 60. Promega Corporation,Personalis Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 61. STC Biologics Revenue Growth Rate in Immune Cell Therapy Drugs Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
